Recombinant human granulocyte-macrophage colony - stimulating factor therapy and endogenous plasma GM - CSF, IL - 3, IL - 4 concentrations in pediatric patients with solid tumors

Turkish Journal of Pediatrics

Volumn 39, Issue 4, 1997, Pages 473-481

  Çetingül, Nazan ^a   Kütükçüler, Necil ^a   Kantar, Mehmet ^a   Kavakli, Kaan ^a   Nişli, Güngör ^a   Çaǧlayan, Suat ^a   Öztop, Senay ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

IL 3; IL 4; Neutropenia; Plasma GM CSF concentration; rHuGM CSF; Solid tumor

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 4; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOLESCENT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; NEOPLASM; NEUTROPENIA; NONPARAMETRIC TEST; PRESCHOOL CHILD; REGRESSION ANALYSIS;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-3; INTERLEUKIN-4; MALE; NEOPLASMS; NEUTROPENIA; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 0031241497     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Diaz-Rubio E. Adrover E. Use of granulocyte growth factors in solid tumors. Eur J Cancer 1994; 30A: 120-122.
2. Henschler R. Brugger W, Kanz L, Mertelsmann R. Haematopoietic-growth factors in clinical medicine. Eur J Cancer 1994; 30A: 118-119.
3. Fink FM, Maurer-Dengg K, Fritsch G, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in septic neutropenic pediatric cancer patients: detection of circulating hematopoietic precursor cells correlates with rapid granulocyte recovery. Med Pediatr Oncol 1995; 25: 365-371.
4. Omori F, Okamura S, Shimoda K, Otsuka T, Harada M, Niho Y. Levels of human granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions. Biotherapy 1992; 4: 147-153.
5. Cebon J, Layton JE, Maher D, Morstyn G. Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 1994; 86: 265-274.
6. Brennscheidt U, Lindemann A. Cytokines in clinical cancer treatment trials: methodoligical aspects [news]. Eur J Cancer 1994; 30A: 412-414.
7. Stein RC, Dalgleish AG, Immunomodulatory agents: the cytokines. Eur J Cancer 1994; 30A: 400-404.
8. Nagai N, Kashiwamura S, Nakanishi K, Shinka S. [Interleukin-4 (IL-4)]. Gan To Kaǵaku Rhoyo 1994; 21: 1099-1108.
9. Siitonen T, Zheng A, Savolainen ER, Koistinen P. The effect of interleukin-4 with or without mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in healthy controls and in myeloproliferative disorders. Ann Hematol 1995; 70: 203-207.
10. Ferrajoli A, Zipf TF, Talpaz M, Felix EA, Estrov Z. Growth factors controlling interleukin-4 action on hematopoietic progenitors. Ann Hematol 1993; 67: 277-284.
11. Raziuddin S, Sheikha A, Abu-Eshy S, al-Janadi M. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies. Cancer 1994; 73: 2426-2431.
12. Hsu SM, Waldron JW Jr, Hsu PL, Hough AJ Jr. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol 1993; 24: 1040-1057.
13. American Society of Clinical Oncology. Recommendations for the use of hematopoietic growth factors: evidence based clinical practice guidelines. J Clin Oncol 1994; 12: 2471-2508.
14. Bennet CL, Smith TJ, Weeks JC, et al. Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. J Clin Oncol 1996; 14: 2511-2520.
15. Weinthal J, Gillan E, Hoder F, et al. G-CSF significantly reduces the nadir of neutropenia, hospitalizations and costs during intensive chemotherapy in children with solid tumors (abstr). Proc Am Soc Clin Oncol 1992; 11: 362.
16. Cebon JS, Bury RW, Lieschke GJ, Morstyn G. The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor. Eur J Cancer 1990; 26: 1064-1069.
17. Gisselbrecht C. Hematopoietic growth factors in practice. Bull Acad Natl Med 1994; 178: 781-792.
18. Millar BC, Bell JB, Millar JL, et al. Colony-stimulating activity in the serum of patients with hemopoietic malignancies after intensive chemotherapy/radiotherapy: its augmentation by GMCSF in vivo and interleukin-4 in vitro. Exp Hematol 1992; 20: 209-215.
19. Galdiero M, Cipollaro de I'Ero G, Folgore A, Cappello M. Giobbe A, Sasso FS. Effects of irradiation doses on alterations in cytokine release by monocytes and lymphocytes. J Med 1994; 25: 23-40.
20. Stasi R, Zinzani L, Galieni P, et al. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma. Eur J Haematol 1995; 54: 9-17.
21. Çetingül N, Yener E, Öztop S, Nisli G. Serum soluble interleukin-2 receptors and tumor necrosis factor-alpha in hematological malignancies of childhood. Acta Paediatr Jpn 1994; 36: 49-52.
22. Elias JA, Tang W, Horowitz MC. Cytokine and hormonal Stimulation of human osteosarcoma interleukin-11 production. Endocrinology 1995; 136: 489-498.
23. Kiyotaki C. [Mechanisms of macrophage activation and macrophage-mediated tumoricidal activity]. Can To Kagaku Ryoho 1989; 16: 3386-3391.
24. Riancho JA, Zarrabeitia MT, Olmos JM, Amado JA, Gonzales-Macias J. Effects of interleukin-4 on human osteoblast-like cells. Bone Miner 1993; 21: 53-61.
25. Report of a WHO Scientific Group. Primary immunodeficiency diseases. Clin Exp Immunol 1995; 99 (Suppl 1): 2-24.
26. Monroy RL, Davis TA, MacVittie TJ. Granulocyte-macrophage colony-stimulating factor: more than a hemopoietin. Clin Immunol Immunopathol 1990; 54: 333-346.
27. th ed). London: Appleton and Lange; 1994: 105-123.
28. Nissen NI, Hovgaard D. Overview of cytokines in clinical practice. In: Proceedings from an International Symposium. Lucerne, Switzerland: September 1993; 3-7.